Shasqi
Targeting Cancer with Click Chemistry
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2015
- Team
- 28 people
- Stage
- Growth stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run the company website and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Shasqi across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Shasqi's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
